back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-02-21 11:33 Tx date 2024-02-20 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,921
+41,600 vol $0.3587 each |
43,959 | |
| Filed 2023-12-26 10:50 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,320
+136,000 vol $0.37 each |
162,139 | |
| Filed 2023-05-16 12:08 Tx date 2023-05-16 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-1,529,847
-1,818 vol $841.50 each |
26,139 | |
| Filed 2023-03-08 13:05 Tx date 2023-03-08 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-696,918.75
-545 vol $1,278 each |
27,957 | |
| Filed 2022-12-19 15:25 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$26,700
+15,000 vol $1.78 each |
28,502 | |
| Filed 2022-11-17 15:08 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,700
+15,000 vol $2.78 each |
||
| Filed 2022-11-15 17:59 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,700
+15,000 vol $2.78 each |
||
| Filed 2022-11-15 17:59 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,700
+15,000 vol $2.78 each |
28,502 | |
| Filed 2022-10-25 18:23 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-56,644 vol |
2,359 | |
| Filed 2022-10-12 17:51 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-56,643 vol |
||
| Filed 2022-10-12 17:51 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-56,643 vol |
2,360 | |
| Filed 2022-10-12 17:48 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-324,074 vol |
13,502 | |
| Filed 2022-06-02 11:47 Tx date 2022-06-02 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-202,494.60
-13,636 vol $14.85 each |
337,576 | |
| Filed 2022-04-14 18:49 Tx date 2022-04-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,659
+14,160 vol $0.89 each |
59,003 | |
| Filed 2022-04-14 18:19 Tx date 2022-04-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,925
+22,720 vol $0.88 each |
||
| Filed 2022-04-14 10:06 Tx date 2022-04-13 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,276
+8,560 vol $0.85 each |
44,843 | |
| Filed 2022-01-24 11:45 Tx date 2022-01-24 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-121,212 vol |
351,212 | |
| Filed 2021-10-19 12:26 Tx date 2021-10-18 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
472,424 | |
| Filed 2021-09-30 11:41 Tx date 2021-09-29 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,224
+8,800 vol $1.73 each |
36,283 | |
| Filed 2021-09-29 11:24 Tx date 2021-09-28 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,984
+11,400 vol $1.75 each |
27,483 | |
| Filed 2020-12-17 11:42 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
347,424 | |
| Filed 2020-11-02 12:07 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-514,642 vol |
16,083 | |
| Filed 2020-11-02 11:57 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-7,117,576 vol |
222,424 | |
| Filed 2019-11-29 12:27 Tx date 2019-11-28 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,000
+100,000 vol $0.25 each |
530,725 | |
| Filed 2019-07-03 16:18 Tx date 2019-07-03 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$34,780
+100,000 vol $0.3478 each |
430,725 | |
| Filed 2019-05-28 12:26 Tx date 2019-05-27 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$408,900
+940,000 vol $0.435 each |
7,340,000 | |
| Filed 2019-01-18 Tx date 2019-01-17 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,064
+40,000 vol $0.50 each |
330,725 | |
| Filed 2019-01-16 Tx date 2019-01-16 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,917
+10,500 vol $0.4683 each |
290,725 | |
| Filed 2019-01-15 Tx date 2019-01-15 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,180
+50,000 vol $0.4836 each |
280,225 | |
| Filed 2018-06-22 Tx date 2018-06-21 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$277,781
+222,225 vol $1.25 each |
222,225 | |
| Filed 2018-06-22 Tx date 2018-06-21 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$200,002
+222,225 vol $0.90 each |
230,225 | |
| Filed 2018-06-22 Tx date 2016-06-16 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-05-17 Tx date 2018-05-16 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,530,000
+1,500,000 vol $1.02 each |
6,400,000 | |
| Filed 2018-03-10 Tx date 2018-03-08 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$697,500
+450,000 vol $1.55 each |
4,900,000 | |
| Filed 2018-01-09 Tx date 2018-01-09 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-438,780.50
-219,500 vol $2.00 each |
8,000 | |
| Filed 2018-01-09 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,324,120.50
-580,500 vol $2.28 each |
227,500 | |
| Filed 2017-06-06 Tx date 2017-06-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$202,500
+450,000 vol $0.45 each |
4,450,000 | |
| Filed 2016-10-04 Tx date 2016-09-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,320
-12,000 vol $0.11 each |
808,000 | |
| Filed 2016-10-04 Tx date 2016-09-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,250
-50,000 vol $0.105 each |
820,000 | |
| Filed 2016-10-04 Tx date 2016-09-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,500
-100,000 vol $0.105 each |
870,000 | |
| Filed 2016-10-04 Tx date 2016-09-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,000
-100,000 vol $0.10 each |
970,000 | |
| Filed 2016-08-17 Tx date 2016-08-17 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,580
+70,000 vol $0.094 each |
1,070,000 | |
| Filed 2016-06-21 Tx date 2016-06-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
| Filed 2016-06-21 Tx date 2016-06-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-15 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$220,000
+2,000,000 vol $0.11 each |
2,000,000 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$115,000
+1,000,000 vol $0.115 each |
1,000,000 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|